Hyperfine (HYPR) announced CE approval of its latest generation of AI-powered Swoop system software under the European Medical Device Regulation. This approval marks a step in positioning Hyperfine ...

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality This major Swoop® system scanner redesign and ...

Hyperfine HYPR recently announced the receipt of FDA 510(k) clearance for the ninth generation of its AI-powered Swoop system software. It is the world’s first FDA-cleared portable magnetic resonance ...

Hyperfine today announced that its FDA-cleared portable magnetic resonance (MR) brain imaging system, called the Swoop system, has gained CE approval for its latest generation of AI-powered software.

A new multi-direction DWI sequence, the latest Swoop® system software, and the first advancement in Hyperfine’s Optive AI™ software, delivers clearer, higher-quality images for stroke diagnosis, ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic ...

Following the recent clearance of the new Swoop® System, two leading hospitals in the United States have purchased the first commercial units, marking the launch of next-generation portable MR brain ...

The U.S. FDA granted 510 (k) clearance to Hyperfine Inc. for improved artificial intelligence (AI)-powered software for its Swoop portable magnetic resonance imaging (MRI) device. The company launched ...

Optive AI™ software has now been installed in an initial set of hospitals and neurology offices across the U.S., marking the beginning of expanded access to transformative, AI-powered image quality ...

This major Swoop® system scanner redesign and Optive AI™ software elevate the AI-powered portable MRI experience for clinicians and their patients across multiple sites of care. GUILFORD, ...